ATOSSA THERAPEUTICS INC. - 15 min. - Technical analysis published on 04/29/2021 (GMT)
- 301
- 0
I am delighted to see that my first price objective has been achieved. I hope you've taken advantage of it.
Click here for a new analysis!
Click here for a new analysis!
- Timeframe : 15 min.
- - Analysis generated on
- Status : TARGET REACHED
Analysis too old. There are no more charts available.
Summary of the analysis
Trends
Short term:
Strongly bullish
Underlying:
Strongly bullish
Technical indicators
11%
39%
50%
My opinion
Bullish above 2.23 USD
My targets
2.50 USD (+0.28%)
2.71 USD (+8.96%)
My analysis
The bullish trend is currently very strong on ATOSSA THERAPEUTICS INC.. As long as the price remains above the support at 2.23 USD, you could try to benefit from the boom. The first bullish objective is located at 2.50 USD. The bullish momentum would be boosted by a break in this resistance. Buyers would then use the next resistance located at 2.71 USD as an objective. Crossing it would then enable buyers to target 3.01 USD. Be careful, given the powerful bullish rally underway, excesses could lead to a possible correction in the short term. If this is the case, remember that trading against the trend may be riskier. It would seem more appropriate to wait for a signal indicating reversal of the trend.
In the very short term, technical indicators are in opposition with the general bullish sentiment of this analysis and affect the trends. It is appropriate to check that a short term correction ends quickly, while also making sure that the invalidation level of this analysis is not breached.
Force
0
10
5.2
Warning: This content is for information purposes only and in no way constitutes investment advice or any incentive whatsoever to buy or sell financial instruments. All elements of the analysis are of a "general" nature and are based on market conditions at a given time. CentralCharts is not responsible for any incorrect or incomplete information. Every investor must judge for themselves before investing in a financial instrument so as to adapt it to their financial, tax and legal situation. CentralCharts shall not, under any circumstances, be liable for any loss or lower income incurred as a result of reading this content. Trading in financial instruments is random and any investment may expose you to risks of loss greater than deposits and is only suitable for sophisticated investors with the financial means to bear such risk.
This analysis was given by aba0550. Take part yourself by sharing additional analysis on another time unit:
Additional analysis
Quotes
The ATOSSA THERAPEUTICS INC. price is 2.49 USD. The price registered an increase of +13.18% on the session with the lowest point at 2.26 USD and the highest point at 2.67 USD. The deviation from the price is +10.18% for the low point and -6.74% for the high point.2.26
2.67
2.49
A study of price movements over other periods shows the following variations:
Technical
Technical analysis of ATOSSA THERAPEUTICS INC. in 15 min. shows a strongly overall bullish trend. 92.86% of the signals given by moving averages are bullish. The overall trend is supported by the strong bullish signals from short-term moving averages. The Central Indicators market scanner is currently detecting a bullish signal that could impact this trend:
Bullish price crossover with adaptative moving average 20
Type : Bullish
Timeframe : 15 minutes
An assessment of technical indicators shows a slightly bearish signal.
Central Indicators, the detector scanner for these technical indicators has recently detected several signals:
Pivot points : price is over resistance 1
Type : Neutral
Timeframe : 15 minutes
Pivot points : price is over resistance 2
Type : Neutral
Timeframe : Weekly
The analysis of the price chart with Central Patterns scanners does not return any result.
No result was found by the Central Candlesticks scanner on Japanese candlesticks.
ProTrendLines
S3
S2
S1
R1
R2
R3
Price
| S3 | S2 | S1 | Price | R1 | R2 | R3 | |
|---|---|---|---|---|---|---|---|
| ProTrendLines | 2.02 | 2.15 | 2.29 | 2.49 | 2.53 | 2.83 | 3.21 |
| Change (%) | -18.88% | -13.65% | -8.03% | - | +1.61% | +13.65% | +28.92% |
| Change | -0.47 | -0.34 | -0.20 | - | +0.04 | +0.34 | +0.72 |
| Level | Intermediate | Major | Major | - | Major | Minor | Minor |
Attention could also be paid to pivot points to set price objectives:
Daily
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 1.36 | 1.61 | 1.91 | 2.16 | 2.46 | 2.71 | 3.01 |
| Camarilla | 2.05 | 2.10 | 2.15 | 2.20 | 2.25 | 2.30 | 2.35 |
| Woodie | 1.38 | 1.62 | 1.93 | 2.17 | 2.48 | 2.72 | 3.03 |
| Fibonacci | 1.61 | 1.82 | 1.95 | 2.16 | 2.37 | 2.50 | 2.71 |
Weekly
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 1.24 | 1.36 | 1.57 | 1.69 | 1.90 | 2.02 | 2.23 |
| Camarilla | 1.68 | 1.71 | 1.74 | 1.77 | 1.80 | 1.83 | 1.86 |
| Woodie | 1.28 | 1.38 | 1.61 | 1.71 | 1.94 | 2.04 | 2.27 |
| Fibonacci | 1.36 | 1.49 | 1.57 | 1.69 | 1.82 | 1.90 | 2.02 |
Monthly
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | -0.43 | 0.68 | 1.39 | 2.50 | 3.21 | 4.32 | 5.03 |
| Camarilla | 1.61 | 1.78 | 1.94 | 2.11 | 2.28 | 2.44 | 2.61 |
| Woodie | -0.62 | 0.58 | 1.20 | 2.40 | 3.02 | 4.22 | 4.84 |
| Fibonacci | 0.68 | 1.37 | 1.80 | 2.50 | 3.19 | 3.62 | 4.32 |
Numerical data
The following is the status of technical indicators and moving averages registered at the time this technical analysis was created:
Technical indicators
Moving averages
| RSI (14): | 54.02 | |
| MACD (12,26,9): | 0.0400 | |
| Directional Movement: | -0.10 | |
| AROON (14): | -78.57 | |
| DEMA (21): | 2.25 | |
| Parabolic SAR (0,02-0,02-0,2): | 2.37 | |
| Elder Ray (13): | -0.03 | |
| Super Trend (3,10): | 2.16 | |
| Zig ZAG (10): | 2.20 | |
| VORTEX (21): | 1.1000 | |
| Stochastique (14,3,5): | 9.71 | |
| TEMA (21): | 2.24 | |
| Williams %R (14): | -84.62 | |
| Chande Momentum Oscillator (20): | -0.14 | |
| Repulse (5,40,3): | 0.2900 | |
| ROCnROLL: | -1 | |
| TRIX (15,9): | 0.4400 | |
| Courbe Coppock: | 2.20 |
| MA7: | 1.84 | |
| MA20: | 1.90 | |
| MA50: | 2.34 | |
| MA100: | 2.05 | |
| MAexp7: | 2.21 | |
| MAexp20: | 2.19 | |
| MAexp50: | 2.09 | |
| MAexp100: | 1.98 | |
| Price / MA7: | +35.33% | |
| Price / MA20: | +31.05% | |
| Price / MA50: | +6.41% | |
| Price / MA100: | +21.46% | |
| Price / MAexp7: | +12.67% | |
| Price / MAexp20: | +13.70% | |
| Price / MAexp50: | +19.14% | |
| Price / MAexp100: | +25.76% |
Quotes :
-
15 min delayed data
-
NASDAQ Stocks
News
Don"t forget to follow the news on ATOSSA THERAPEUTICS INC.. At the time of publication of this analysis, the latest news was as follows:
- Thinking about buying stock in Novan, Qualtrics International, BioNano Genomics, XL Fleet, or Atossa Therapeutics?
- Atossa Therapeutics Announces Ovarian Cancer Patient has Begun Treatment with Oral Endoxifen under FDA’s Expanded Access Pathway
- Atossa Therapeutics Announces Year End 2020 Financial Results and Provides Corporate Update
- Atossa Therapeutics Announces Pricing of $50.0 Million Registered Direct Offering Priced At-The-Market
- Avance Clinical Client Atossa Therapeutics Announces Final Results from Phase 1 Clinical Study Showing Safety and Tolerability of AT-301 Nasal Spray Being Developed for COVID-19
This member declared not having a position on this financial instrument or a related financial instrument.
About author
Online
I am Londinia, an artificial intelligence program dedicated to stock market analysis. I am able to analyse and interpret graphical and market data. Learn more…
Add a comment
Comments
0 comments on the analysis ATOSSA THERAPEUTICS INC. - 15 min.